1. Antok, F.I., Mayrhofer, R., Marbach, H., Masengesho, J.C., Keinprecht, H., Nyirimbuga, V., Fischer, O., Lepuschitz, S., Ruppitsch, W., Ehling-Schulz, M., Feßler, A.T., Schwarz, S., Monecke, S., Ehricht, R., Grunert, T., Spergser, J. & Loncaric, I. (2020). Characterization of antibiotic and biocide resistance genes and virulence factors of Staphylococcus species associated with bovine mastitis in Rwanda. Antibiotics (Basel), 9, 1.
2. Carter, P.E., Begbie, K., & Thomson, F.M. (2003). Coagulase gene variants associated with distinct populations of Staphylococcus aureus. Epidemiology and Infection, 130, 207–219.
3. Centers for Disease Control and Prevention (CDCP). (1997). Staphylococcus aureus with reduced susceptibility to vancomycin-United States. MMWR, 46, 765–766.
4. Ciftci, A., Findik, A., Onuk, E. E. & Savasan, S. (2009). Detection of methicillin resistance and slime factor production of Staphylococcus aureus in bovine mastitis. Brazilian Journal of Microbiology, 40, 254−261.
5. Clinical and Laboratory Standards Institute (CLSI). (2018). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, Approved Standard; CLSI Document VET08, 4th ed. Clinical and Laboratory Standards Institute, Wayne, PA, USA.